Results of Antiretroviral Treatment Interruption and Intensification in Advanced Multi-Drug Resistant HIV Infection from the OPTIMA Trial

• Mark Holodniy,

  Affiliations VA Palo Alto Health Care System, Palo Alto, California, United States of America, Department of Medicine, Stanford University, Stanford, California, United States of America

  ⨯
• Sheldon T. Brown,

  Affiliations James J. Peters VA Medical Center, Bronx, New York, United States of America, Department of Medicine, Mt. Sinai School of Medicine, New York, New York, United States of America

  ⨯
• D. William Cameron ,

  * E-mail: bcameron@ohri.ca

  Affiliations University of Ottawa at The Ottawa Hospital Research Institute, Ottawa, Ontario, Canada, Canadian HIV Trials Network, St Paul's Hospital, Vancouver, British Columbia, Canada

  ⨯
• Tassos C. Kyriakides,

  Affiliation VA Cooperative Studies Program Coordinating Center, West Haven, Connecticut, United States of America

  ⨯
• Brian Angus,

  Affiliation Nuffield Department of Medicine, The John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom

  ⨯
• Abdel Babiker,

  Affiliation MRC Clinical Trials Unit, London, United Kingdom

  ⨯
• Joel Singer,

  Affiliation Canadian HIV Trials Network, St Paul's Hospital, Vancouver, British Columbia, Canada

  ⨯
• Douglas K. Owens,

  Affiliations VA Palo Alto Health Care System, Palo Alto, California, United States of America, Department of Medicine, Stanford University, Stanford, California, United States of America

  ⨯
• Aslam Anis,

  Affiliation Canadian HIV Trials Network, St Paul's Hospital, Vancouver, British Columbia, Canada

  ⨯
• Ruth Goodall,

  Affiliation MRC Clinical Trials Unit, London, United Kingdom

  ⨯
• Fleur Hudson,

  Affiliation MRC Clinical Trials Unit, London, United Kingdom

  ⨯
• Mirek Piaseczny,

  Affiliation Canadian HIV Trials Network, St Paul's Hospital, Vancouver, British Columbia, Canada

  ⨯
• John Russo,

  Affiliation VA Cooperative Studies Program Coordinating Center, West Haven, Connecticut, United States of America

  ⨯
• Martin Schechter,

  Affiliation Canadian HIV Trials Network, St Paul's Hospital, Vancouver, British Columbia, Canada

  ⨯
• Lawrence Deyton,

  Current address: United States Food and Drug Administration, Silver Spring, Maryland, United States of America

  Affiliation Department of Veterans Affairs, Office of Public Health and Environmental Hazards, Washington, D.C., United States of America

  ⨯
• Janet Darbyshire,

  Affiliation MRC Clinical Trials Unit, London, United Kingdom

  ⨯
•  [ ... ],
• for the OPTIMA Team
• [ view all ]
• [ view less ]